Parallel raises €20M for AI agents that tackle hospital administrative bottlenecks
An estimated 30% of healthcare spending—approximately $1 trillion annually in the US alone—goes to administration rather than patient care. Behind this figure lies a maze of legacy software, manual workflows, and integration projects that stretch for months or years before delivering value, if they succeed at all.
This administrative burden has become healthcare’s defining operational bottleneck, consuming resources that could otherwise expand care capacity while creating delays that directly affect patient outcomes and hospital revenue. The core challenge isn’t the absence of solutions—it’s that existing automation approaches require deep system integrations that hospital IT departments often cannot execute or afford.
The Legacy Software Integration Problem
Hospital administrative workflows rest on software architectures built decades ago, when interoperability meant printing reports and faxing them between departments. Today’s hospitals run dozens of specialized systems that rarely communicate effectively: electronic health records, billing platforms, coding software, insurance verification tools, and compliance reporting systems.
Medical coding exemplifies the complexity. Every patient discharge triggers a process where clinical information must be converted into standardised ICD codes and procedure classifications that determine reimbursement. In French public hospitals, this involves navigating the PMSI (Programme de Médicalisation des Systèmes d’Information) framework, a particularly intricate coding structure that requires specialised training.
Traditional automation approaches require API access, database integration, or workflow redesign—changes that can take 12 to 24 months to implement and often fail during testing phases. The result is that trained medical information specialists spend most of their working hours on data entry rather than more complex analytical tasks.
Computer-Use Agents as Infrastructure Layer
Parallel, a Paris-based startup founded in 2024, announced a $20 million Series A this week led by Index Ventures, less than a year after its €3.5 million seed round. The company has developed AI agents that operate directly on top of existing hospital software, learning to navigate user interfaces the way human workers do—reading screens, clicking through workflows, and entering data without requiring API access or back-end modifications.
The technical approach represents a fundamental shift in enterprise AI deployment strategy. Rather than building integrations that connect systems at the data layer, Parallel’s agents function at the user interface layer, treating legacy software as a black box that can be automated through interface interaction.
Co-founder and CEO Paul Lafforgue, who previously worked at Meta and McKinsey after graduating from École polytechnique and HEC, describes the approach as “running a layer on top of existing hospital software—no replacement, no complex integration.” Co-founder and CTO Christopher Rydahl brings healthcare software experience as a co-founder of Hublo, which became Europe’s largest healthcare staffing platform and raised €22 million by 2021.
Evidence of Hospital Adoption
Parallel reports that its AI agents are already deployed across several dozen public and private hospitals in France, with deployment timelines measured in days rather than months. The company’s initial focus on medical coding has produced measurable improvements in both speed and accuracy, though specific performance metrics have not been independently verified.
The deployment approach addresses a critical constraint in hospital operations: IT departments that are understaffed, risk-averse, and operating with limited budgets for major system changes. By eliminating the integration requirement, Parallel’s agents can be tested and deployed without the extensive IT project management that typically accompanies healthcare automation initiatives.
Julia Andre, Partner at Index Ventures, noted in the funding announcement: “The speed with which hospitals see the real impact of Parallel’s AI agents has been truly impressive. AI agents present a huge opportunity for hospitals across the entire patient lifecycle, ensuring time and resources are invested where it matters the most.”
Market Implications and Infrastructure Emergence
The successful deployment of AI agents in hospital environments signals a broader shift in enterprise automation strategy. Traditional enterprise software companies have focused on system replacement or deep integration approaches that require significant IT investment and change management. Computer-use agents represent an alternative path that can deliver automation benefits while working within existing technology constraints.
Healthcare represents a particularly compelling test case for this approach because of the sector’s combination of high administrative costs, legacy infrastructure, and resistance to disruptive technology changes. If AI agents can demonstrate value in this environment, the approach becomes applicable to other highly regulated industries with similar technology constraints.
The funding round included participation from existing investors Frst, Y Combinator, and Hexa, with angel investors including Arthur Mensch (CEO of Mistral AI) and the founders of French fintech Pennylane. This investor profile suggests confidence that the approach can scale beyond individual hospital deployments to broader healthcare system adoption.
Looking Forward: Workflow Expansion and International Growth
Parallel plans to use the Series A funding to expand from medical coding into billing, admissions, and insurance verification workflows—each representing a significant administrative function that currently requires manual intervention. The company also intends to expand beyond France into other European markets with similar healthcare system structures, including the Netherlands and Belgium.
The international expansion timeline will likely depend on regulatory validation in each market and the company’s ability to adapt its agents to different national healthcare coding frameworks and administrative requirements. Success in this expansion could establish computer-use agents as a standard approach for healthcare automation across European public health systems.
The longer-term question is whether this UI-layer automation approach can maintain effectiveness as hospital software vendors begin designing interfaces specifically to prevent automated interaction, or whether it will drive software vendors toward more API-accessible architectures to compete with agent-based alternatives.
Parallel’s approach to hospital automation reflects broader infrastructure trends toward deployment methods that work within existing enterprise constraints rather than requiring wholesale system replacement. For organisations evaluating AI agent implementations, Overclock’s orchestration platform provides governance and coordination capabilities that ensure agent deployments remain auditable and aligned with enterprise compliance requirements as they scale across multiple workflows and departments.